AU2002243300A1 - Human genes and gene expression products isolated from human prostate - Google Patents

Human genes and gene expression products isolated from human prostate

Info

Publication number
AU2002243300A1
AU2002243300A1 AU2002243300A AU2002243300A AU2002243300A1 AU 2002243300 A1 AU2002243300 A1 AU 2002243300A1 AU 2002243300 A AU2002243300 A AU 2002243300A AU 2002243300 A AU2002243300 A AU 2002243300A AU 2002243300 A1 AU2002243300 A1 AU 2002243300A1
Authority
AU
Australia
Prior art keywords
human
gene expression
expression products
products isolated
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002243300A
Other languages
English (en)
Inventor
Radomir Crkvenjakov
Mark Dickson
Radoje Drmanac
Snezana Drmanac
Jaime Escobedo
Pablo Dominguez Garcia
Veronica Garcia
William Lee Jones
Altaf Kassam
David Kita
Ivan Labat
George Lamson
Dena Leshkowitz
Elizabeth M. Scott
Birgit Stache-Crain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Hyseq Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of AU2002243300A1 publication Critical patent/AU2002243300A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002243300A 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate Abandoned AU2002243300A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25464800P 2000-12-07 2000-12-07
US60/254,648 2000-12-07
US27568801P 2001-03-13 2001-03-13
US60/275,688 2001-03-13
PCT/US2001/047349 WO2002055700A2 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Publications (1)

Publication Number Publication Date
AU2002243300A1 true AU2002243300A1 (en) 2002-07-24

Family

ID=26944174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002243300A Abandoned AU2002243300A1 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Country Status (5)

Country Link
EP (1) EP1379651A2 (ja)
JP (1) JP2004526429A (ja)
AU (1) AU2002243300A1 (ja)
CA (1) CA2430794A1 (ja)
WO (1) WO2002055700A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
AU2002246708A1 (en) 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005080562A1 (ja) * 2004-02-23 2005-09-01 Hiroshi Yamamoto 前立腺癌の判定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Also Published As

Publication number Publication date
EP1379651A2 (en) 2004-01-14
WO2002055700A3 (en) 2003-10-23
CA2430794A1 (en) 2002-07-18
JP2004526429A (ja) 2004-09-02
WO2002055700A2 (en) 2002-07-18
WO2002055700A8 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
AU6069300A (en) Novel human genes and gene expression products
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2095599A (en) Human genes and gene expression products i
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AUPP249298A0 (en) Synthetic genes and genetic constructs comprising same I
AU6037199A (en) Rac-like genes from maize and methods of use
AU3869400A (en) Human cancer associated gene sequences and polypeptides
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU2002327607A1 (en) Human genes and gene expression products isolated from human prostate
AU2088801A (en) Metastasis genes and uses thereof
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AUPQ262599A0 (en) Gene expression
AU2001226922A1 (en) Cancer associated genes and their products
AU1101901A (en) Human fgf-20 gene and gene expression products
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
AU6263999A (en) Human genes and gene expression products
AU2001287269A1 (en) Human genes and expression products
AU2001256232A1 (en) Genes isolated from dendritic cells, gene products and methods employing the same
AU2001269077A1 (en) Methods and means for regulation of gene expression
GB9828840D0 (en) Prostate cancer associated genes and their products
AU6773200A (en) Egfh2 genes and gene products
AU3133799A (en) Seed-coat promoters, genes and gene products

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase